Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Daily Ledger.
Press releases published on June 9, 2025
MICROSTRATEGY INCORPORATED (NASDAQ: MSTR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MicroStrategy Incorporated Investors of Upcoming Deadline
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) investors of an upcoming deadline involving …
DOUBLEVERIFY HOLDINGS, INC. (NYSE: DV) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds DoubleVerify Holdings, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”) (NYSE: DV) investors of an upcoming deadline involving a securities …
COMPASS DIVERSIFIED HOLDINGS (NYSE: CODI) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Compass Diversified Holdings Investors of Upcoming Deadline
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Compass Group Diversified Holdings, LLC, and Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) investors of an …
DIGIMARC CORPORATION (NASDAQ: DMRC) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Digimarc Corporation Investors of Upcoming Deadline
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC) investors of an upcoming deadline involving a securities fraud …
UROGEN PHARMA LTD. (NASDAQ: URGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds UroGen Pharma Ltd. Investors of Upcoming Deadline
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) investors of an upcoming deadline involving a securities fraud class …
FORTREA HOLDINGS INC. (NASDAQ: FTRE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Fortrea Holdings Inc. Investors of Upcoming Deadline
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors of an upcoming deadline involving a securities fraud …
OnePay and Synchrony to Launch New Industry-Leading Credit Card Program With Walmart; Credit Card to Be Powered by Mastercard and Set to Go Live This Fall
GlobeNewswire
·
June 9, 2025
Synchrony to become exclusive issuer of OnePay credit cards at Walmart, with the credit card experience embedded inside the OnePay app The program will add credit cards to OnePay’s growing portfolio of financial services products, helping consumers save, …
Reade Hotel Management Announces Transition from USLI Hospitality Management
EIN Presswire
·
June 9, 2025
Strategic Shift Aims to Enhance Hotel Operations and Guest Experience NEW YORK, NY, UNITED STATES, June 8, 2025 /EINPresswire.com/ -- Reade Hotel Management is pleased to announce its transition from USLI Hospitality Management to better align with …
LifeMD to Participate in Two Investor Conferences During June
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity …
GraniteShares Announces Weekly Distribution Schedule For YieldBOOST ETFs
GlobeNewswire
·
June 9, 2025
New York, June 09, 2025 (GLOBE NEWSWIRE) -- GraniteShares, a leading innovator in exchange-traded funds (ETFs), is pleased to announce that its YieldBOOST ETF family will update to a weekly distribution schedule. Designed with the goal of providing …
Mizuho Wins 2025 Global Markets Choice Awards for Best in CLOs and Best in Equity Research
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Mizuho Americas today announced it won 2025 Global Markets Choice Awards for Best in CLOs (Collateralized Loan Obligations) and Best in Equity Research. Launched in 2022, Mizuho Americas’ CLO team has rapidly …
Aether Holdings Expands Relationship With AI Experienced Digital Media and Data Operations Leaders Eva and Luke Hodgens
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Aether Holdings, Inc. (Nasdaq: ATHR) ("we," "us," "our," “Aether,” or the “Company”), an emerging financial technology platform company that offers proprietary research analytics, today announced the appointment …
Plug Power and Allied Green Expand Strategic Collaboration with New 2 GW Electrolyzer Deal in Uzbekistan
GlobeNewswire
·
June 9, 2025
Plug Power and Allied Green Leadership attending International Investment Forum to Execute the Agreement Allied Green Continues to Make Meaningful Progress in its Green Ammonia Plant in Australia with Plug to supply 3GW of Electrolyzer Capacity Bringing …
Outbrain Completes Change of Corporate Name to Teads
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand following Outbrain’s acquisition of Teads in February 2025, announced today that the combined company has completed its corporate renaming …
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced that Patient 009 in the Phase 1 trial of …
Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i
GlobeNewswire
·
June 9, 2025
Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination Well-tolerated with no safety signals Company to host …
Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia
GlobeNewswire
·
June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it has received a Refusal to File (RTF) letter …
IBTA IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ibotta, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – IBTA
GlobeNewswire
·
June 9, 2025
NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ibotta, Inc. (NYSE: IBTA): (1) pursuant and/or traceable to the registration statement and related prospectus ( …
המועד האחרון החשוב לתביעה נגד IBTA: רוזן, יועץ למשקיעים מהימן, מעודד את משקיעי Ibotta, Inc עם הספסדים של יותר מ- 1000 אלף דולר, להבטיח ייעוץ לפני מועד חשוב בתביעה ייצוגית בניירות ערך שהוגשה לראשונה על ידי המשרד - IBT…
GlobeNewswire
·
June 9, 2025
ניו יורק, June 09, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Ibotta, Inc.. (NYSE: IBTA): בהתאם ו/או ניתן לעקוב אחר הצהרת הרישום והתשקיף הקשור (ביחד, …